VEGFA and age-related macular degeneration: Several multi-center, randomized, prospective studies have demonstrated anti-VEGF agents to be an effective treatment option for diabetic macular edema, retinal vein obstruction macular edema, and exudative age-related macular degeneration (AMD) [19-22].